BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38361758)

  • 1. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.
    Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM
    Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of miR-34a in Bone Marrow Mononuclear Cells of Acute Myeloid Leukemia Patients.
    Liu X; Li H
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of MiR-34a/b/c Expression with Treatment Response and Prognosis of Elderly Patients with Acute Myeloid Leukemia].
    Li H; Bao HX; Qin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):476-483. PubMed ID: 32319382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a.
    Wang CH; Li QY; Nie L; Ma J; Yao CJ; Chen FP
    Int J Biochem Cell Biol; 2020 Feb; 119():105666. PubMed ID: 31830533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
    Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients.
    Qi X; Zhang Y
    Pediatr Hematol Oncol; 2022 Sep; 39(6):500-507. PubMed ID: 35044282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
    Zhang P; Sun D; Sun X; Li H
    Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
    Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
    J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia.
    Zhang TJ; Guo H; Zhou JD; Li XX; Zhang W; Ma JC; Wen XM; Yao XY; Lin J; Qian J
    Pathol Res Pract; 2018 Jan; 214(1):169-173. PubMed ID: 29254789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of miR-96 in patients with acute myeloid leukemia.
    Zhao J; Lu Q; Zhu J; Fu J; Chen YX
    Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
    Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
    Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
    Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
    Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
    Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
    Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
    Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
    Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.
    Wang Z; Hong Z; Gao F; Feng W
    Mol Cell Biochem; 2013 Nov; 383(1-2):59-65. PubMed ID: 23864342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.